Natasha Giordano

2018

In 2018, Natasha Giordano earned a total compensation of $616K as President, Chief Executive Officer and Director at Dipexium Pharmaceuticals, a 36% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$200,000
Salary$400,000
Other$16,000
Total$616,000

Giordano received $400K in salary, accounting for 65% of the total pay in 2018.

Giordano also received $200K in non-equity incentive plan and $16K in other compensation.

Rankings

In 2018, Natasha Giordano's compensation ranked 11,190th out of 14,244 executives tracked by ExecPay. In other words, Giordano earned more than 21.4% of executives.

ClassificationRankingPercentile
All
11,190
out of 14,244
21st
Division
Manufacturing
4,522
out of 5,759
22nd
Major group
Chemicals And Allied Products
1,712
out of 2,122
19th
Industry group
Drugs
1,452
out of 1,811
20th
Industry
Pharmaceutical Preparations
1,113
out of 1,385
20th
Source: SEC filing on September 25, 2020.

Giordano's colleagues

We found three more compensation records of executives who worked with Natasha Giordano at Dipexium Pharmaceuticals in 2018.

2018

Rita O'Connor

Dipexium Pharmaceuticals

Chief Financial Officer

2018

Efthymios Deliargyris

Dipexium Pharmaceuticals

Chief Medical Officer

2018

Michael Valentino

Dipexium Pharmaceuticals

Chairman

News

You may also like